Concepedia
Statistics
Publications
13
Citations
589
H-Index
12
Active since
2011
Affiliations
University of British Columbia(Current)
McGill University
Jewish General Hospital
Saskatchewan Health Quality Council
University of Manitoba
Anat Fisher is an author at University of British Columbia specializing in pharmacoepidemiology, pharmacotherapy, and pharmacology.
Publications per year
2011–2023
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis
Antonios Douros, Lisa M. Lix, Michael Fralick et al. · Annals of Internal Medicine · 2020 · 178 citations
Medicine, Pharmacology, Pharmacotherapy +17
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Kristian B. Filion, Lisa M. Lix, Oriana HY Yu et al. · BMJ · 2020 · 122 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +16
Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
Anat Fisher, Ken Bassett, James M Wright et al. · PLoS ONE · 2014 · 41 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications
Colin R. Dormuth, Jason D. Kim, Anat Fisher et al. · JAMA Network Open · 2023 · 41 citations · Full text
Medicine, Infectious Diseases, Pharmacotherapy +11
Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study
Oriana Hoi Yun Yu, Sophie Dell’Aniello, Baiju R. Shah et al. · Diabetes Care · 2020 · 40 citations
Pharmacy, Pharmacology, Pharmacotherapy +14
1–5 of 13